Winship Cancer Institute and the University of Georgia recently hosted nearly 100 researchers for the 2023 UGA-Winship Cancer Research Summit in Athens, Ga. This year’s summit highlighted the research strengths of the two institutions and explored opportunities to collaborate on cancer prevention, diagnosis and treatment efforts. Pictured: UGA poster presenter Nikitha Sundaresha shares findings with Carlos Moreno, PhD, Winship's assistant director for education and training.
Researchers from Winship and Case Western Reserve University led by Anant Madabhushi, PhD, have developed a method using artificial intelligence and machine learning to analyze imaging scans and determine whether a combination treatment using CDK4/6 inhibitors will be effective in patients with metastatic breast cancer. Findings from their study were recently published in the journal npj Breast Cancer.
Six investigators will receive $300,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship. Pictured (clockwise from top left): pilot grant recipients Candace Fleischer, PhD, Homa Ghalei, PhD, Kimberly Hoang, MD, Kevin Kalinsky, MD, MS, Yong Teng, PhD, and Yong Wan, PhD.
Winship Executive Director Suresh Ramalingam, MD, and Deputy Director Adam Marcus, PhD, recently presented at the Chattooga Club Speakers Bureau in Cashiers, N.C. The event was hosted by Ann and Bill Viehman, former Winship Advisory Board co-chairs.
The Rollins Immediate Care Center, located at Emory University Hospital, has expanded its hours and now provides 24-hour care Monday through Friday, and from 7:00 a.m. to 7:00 p.m. on Saturday. The facility, along with the Immediate Care Center at Winship at Emory Midtown, provides specialized care to Winship patients experiencing cancer-related symptoms that require immediate attention.
Tori's biopsy revealed she had Hodgkin lymphoma. Following successful treatment, she relapsed and went to Winship where she received a stem cell transplant and "top notch" care that has given her hope.
The Constructive Collisions event series continues on Sept. 6, 8:45-11 a.m., in the R. Randall Rollins Building. The event will include informational and networking opportunities to connect Emory researchers with big ideas relevant to imaging, AI and precision interventions for digital surgery. Registration closes on Aug. 30.
Join the Emory Stem Cell Core for a special workshop Oct. 16-17 to learn somatic cell reprogramming and induced pluripotent stem cell (iPSC) maintenance. Space is limited; reserve your spot by Sept. 1.
Below are four selected Winship publications out of 62 published over the past week:
Jhaveri K, Eli LD, Wildiers H, Hurvitz SA, Guerrero-Zotano A, Unni N, Brufsky A, Park H, Waisman J, Yang ES, Spanggaard I, Reid S, Burkard ME, Vinayak S, Prat A, Arnedos M, Bidard FC, Loi S, Crown J, Bhave M, Piha-Paul SA, Suga JM, Chia S, Saura C, Garcia-Saenz JÁ, Gambardella V, de Miguel MJ, Gal-Yam EN, Rapael A, Stemmer SM, Ma C, Hanker AB, Ye D, Goldman JW, Bose R, Peterson L, Bell JSK, Frazier A, DiPrimeo D, Wong A, Arteaga CL, Solit DB.
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.Annals of Oncology. 2023; PubMed PMID: 37597578.
Have a story for Winship Weekly? Submit your news here.
About Winship Cancer Institute of Emory University The coordinating center for cancer research, education and care throughout Emory University and Emory Healthcare, Winship Cancer Institute of Emory University is Georgia’s only National Cancer Institute-designated Comprehensive Cancer Center, a prestigious distinction given only to the top 3% of cancer centers nationwide for conducting cancer research, and providing training, that is transforming cancer care, prevention, detection and survivorship.